Please assess the completion status of the following clinical trial:

Trial Title: Renin Angiotensin System Study (RASS/B-RASS)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: None
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* type 1 diabetic (DM) for 2-20 yrs~* type 1 DM onset prior to 45; if onset was between ages 31-41, BMI \<26; onset 41-45, positive GAD or ICA required~* normal or increased GFR~* normal BP~* normoalbuminuric (\<20 ug/min on 2 of 3 time overnight urine collections)~Exclusion Criteria:~* type 1 DM duration longer than 20 yrs~* hypertension (\>85/135 mmHg)~* reduced GFR (\<90 ml/min/1.73m2)~* microalbuminuria~* solitary kidney or evidence of unilateral renal disease~* evidence of other important kidney disease by history, ultrasound or biopsy~* other chronic diseases or conditions such as cystic fibrosis, serious mental illness, severe mental retardation, etc.~* pregnancy or females planning pregnancy within 2 years were excluded due to the drugs being used~* compliance (pt not taking at least 85% of two week placebo were excluded)

- Gender: ALL
- Minimum Age: 16 Years
- Maximum Age: 61 Years
- Healthy Volunteers: t

Based on this trial design, predict the completion outcome and termination type (if applicable).